Mode
Text Size
Log in / Sign up
N/A N=69 Treatment

PTSD Treatment for Incarcerated Men and Women: NIMH

PTSD

Enrolled (actual)
69
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Number and Percentage of Participants That Attend All Offered Cognitive Processing Therapy Sessions — 31; 32 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive Processing Therapy (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Wisconsin, Madison
Primary completion
Jul 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Number and Percentage of Participants That Attend All Offered Cognitive Processing Therapy Sessions
31; 32
PRIMARY
Change in Self-reported PTSD Symptoms (PCL-5)
-19.07; -12.94
PRIMARY
Mean Scores on the CSQ-8 (Client Satisfaction Questionnaire)
28.48; 25.7
SECONDARY
Percentage of Individuals That Meet Study Inclusion Criteria
43; 36
SECONDARY
Percentage of Eligible Individuals Enrolled in the Study
35; 34
SECONDARY
Number of Participants Attending Greater Than or Equal to 75% of Sessions (Attendance)
31; 30
SECONDARY
Percentage of Retained Participants That Completed at Least >80% of Assigned Worksheets
21; 22
SECONDARY
Percentage of Session Elements That Were Rated "Present" (Versus "Absent") by a Clinical Supervisor
87.72; 85.96
SECONDARY
Ratings 1-5 by Clinical Supervisors on Quality of Session Elements Delivered by Therapist
4.67; 4.35; 4.77; 4.36
SECONDARY
Number of Participants Reporting Increased Suicidality Over the Course of Treatment (Endorsing 2 or Higher on Question #9 of BDI-II)
0; 2
SECONDARY
Reasons for Participant Discontinuation
1; 0; 1; 0; 1; 0

Summary

Study examining the feasibility of and psychological response to group Cognitive Processing Therapy (CPT) in incarcerated men and women with Post-traumatic stress disorder (PTSD). The study will be conducted in male and female incarcerated populations and will include 2 groups of 10 individuals for CPT in both populations (i.e., 40 participants total; 20F/20M). The study will run for up to 2 years. Participants can expect to be participating in study for up to 22 weeks.

Eligibility Criteria

Inclusion Criteria

  • Intelligence quotient (IQ) greater than or equal to 70
  • 18 years old or older
  • Reading level of 4th grade or higher
  • stable medication use (same medication for at least one month)
  • able and willing to participate in group therapy
  • meet PCL-5 criteria for a current PTSD diagnosis within two months of study enrollment
  • no scheduled release date before the end of the treatment group

Exclusion Criteria

  • currently enrolled in trauma focused treatment that is historical or involves processing of trauma itself
  • no active symptoms of psychosis that would interfere with the individual's ability to participate in the group
  • no active suicidal ideation with intent or plan
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05168267). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search